FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Micro Labs Usa, Inc S Glimepiride Tablets Recall

GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bo…

Micro Labs Usa, Inc S · Princeton, NJ

Risk level
Class II
Reported by FDA
Nov 5, 2014
Recall ID
D-0046-2015
Check your lot numberHow we source this data

Summary

Micro Labs Usa, Inc S recalled Glimepiride Tablets starting Oct 9, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0046-2015 on Nov 5, 2014. Reason: Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing. Status: Terminated.

Why it was recalled

Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.

Product description

GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540

Lot numbers, UPCs & expiration codes

GLBG001 Exp.12/14, GLBG008 Exp. 06/15

Where it was sold

CT, FL, MD, MS, NY

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0046-2015
Classification
Class II
Status
Terminated
Recall initiated
Oct 9, 2014
FDA report date
Nov 5, 2014
Quantity
11,328 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Micro Labs Usa, Inc S

Original FDA data

Every field from FDA enforcement report D-0046-2015, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
69133
Address
104 Carnegie Ctr
Address (line 2)
Te 216
Code information
GLBG001 Exp.12/14, GLBG008 Exp. 06/15
Postal code
08540-6232
Report date
Nov 5, 2014
Product type
Drugs
Recall number
D-0046-2015
Classification
Class II
Recalling firm
Micro Labs Usa, Inc S
Product quantity
11,328 bottles
Termination date
Dec 29, 2015
Reason for recall
Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540
Distribution pattern
CT, FL, MD, MS, NY
Recall initiation date
Oct 9, 2014
Initial firm notification
Letter
Center classification date
Oct 27, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0046-2015, published Nov 5, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls